New combo vaccine targets deadly diarrhea in kids
NCT ID NCT05987488
First seen Jan 25, 2026 · Last updated May 09, 2026 · Updated 11 times
Summary
This study tested a new vaccine called ShigETEC in 196 healthy Bangladeshi adults and children. The vaccine aims to protect against two bacteria that cause severe diarrhea. Researchers checked if the vaccine is safe and if it triggers an immune response. This is an early-phase trial to see if the vaccine is promising enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
International Centre for Diarrhoeal Diseases Research, Bangladesh (icddr,b)
Dhaka, Bangladesh
Conditions
Explore the condition pages connected to this study.